Veno-occlusive dysfunction has become a recognized cause of organic impotence. The existence of concomitant arterial and sinus smooth-muscle disease makes this disorder often difficult to diagnose. It rarely can be the sole etiology for impotence. The authors’ experience in the treatment of this disorder in over 100 patients is presented. The authors rely on cavernosometry/pharma-cocavernosometry/pharmacocavernosography and the color duplex Doppler screening test (to eliminate concomitant arterial disease) as the primary diagnostic tools. Twenty-two patients of 58 (38%) have achieved long-lasting success from the surgery so that they are able to have vaginal intercourse. Another 12 patients (21 %) have been improved but must depend upon pharmacological injection therapy to obtain a sufficient erection for intercourse. There has been a 41% failure rate, and these are discussed.

Keywords:
Veno-occlusive erectile dysfunction, Diagnosis and surgical management, Organic impotence, Penile vein dissection and ligation, Cavernosometry, Cavernosography
This content is only available via PDF.
© 1992 S. Karger AG, Basel
1992
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.